Literature DB >> 10921419

Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis.

T Ishikawa1, T Ichida, Y Matsuda, S Sugitani, M Sugiyama, T Kato, H Miyazaki, H Asakura.   

Abstract

BACKGROUND AND AIMS: The main causes of thrombocytopenia in cirrhosis are thought to be platelet destruction and the reduction of thrombopoietin (TPO) expression in the liver. The mechanisms by which levels of TPO mRNA are regulated in cirrhosis have not been elucidated. In this study, we investigated some possible mechanisms.
METHODS: We used three experimental models: bone marrow suppression, acute liver injury and primary cultured hepatocytes. We used northern blots to assess the kinetics of TPO mRNA expression in the livers of irradiated rats (with and without cirrhosis) in acute liver injury and in primary cultured hepatocytes treated with hepatotoxin or cytokines.
RESULTS: Although the bone marrow was hypocellular, there was no apparent enhancement of TPO mRNA expression in the irradiated rats with cirrhotic livers compared with the unirradiated rats with cirrhotic livers. There were no conspicuous changes in hepatic TPO mRNA expression between the livers of the control rats and the three models of acute liver injury. There were no conspicuous changes in the levels of TPO mRNA between control hepatocytes and hepatocytes treated with hepatotoxin or cytokines.
CONCLUSIONS: Our results suggest that bone marrow is not a regulator of hepatic TPO production in cirrhosis. The reduced TPO mRNA expression found in cirrhotic rats may not result merely from serious cellular damage; it may be associated with cirrhosis-specific regulatory mechanisms for the expression of the TPO gene. Further studies are needed to search for other factors that may induce reduced TPO expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921419     DOI: 10.1046/j.1440-1746.2000.02087.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

Review 1.  Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures.

Authors:  Paolo Gallo; Francesca Terracciani; Giulia Di Pasquale; Matteo Esposito; Antonio Picardi; Umberto Vespasiani-Gentilucci
Journal:  World J Gastroenterol       Date:  2022-08-14       Impact factor: 5.374

2.  Analysis of predictors after partial splenic embolization for thrombocytopenia with liver cirrhosis.

Authors:  Toru Ishikawa; Kazuki Ohashi; Erina Kodama; Takamasa Kobayashi; Motoi Azumi; Yujiro Nozawa; Akito Iwanaga; Tomoe Sano; Terasu Honma
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.